| Name | Title | Contact Details |
|---|
Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.
Preferred Health Systems is a Wichita, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Say goodbye to a blanket approach to healthcare. We personalize each plan sponsor`s needs toward improving the health and quality of life of participants. The result? Reduced healthcare spend and a healthier population. HMC`s 40 years of clinically-based protocols produces an impact that engages, empowers and delivers.
Fallon Ambulance Service was founded in 1936 by James Fallon Sr. and remains a family operated business to this day. Fallon Ambulance employs more than 525 personnel, including 125 Paramedics and 375 EMTs, and operates 115 vehicles. The company provides
Milliman Care Guidelines is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.